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Background: Initially, patients with a short angulated aortic neck were considered unfit for endovascular aneurysm repair
(EVAR). Recently, however, more liberal use of EVAR has been advocated. This study analyzes the correlation of aortic
neck length to early and late outcomes.
Methods: We analyzed 238 patients who underwent EVAR during a recent 7-year period. All patients were followed up
clinically and underwent postoperative duplex ultrasound imaging or computed tomography angiography, which were
repeated every 6 months. Aortic neck length was classified into>15 mm (L1, n 195), 10 to<15 mm (L2, n 24), and
<10 mm (L3, n  17). Kaplan-Meier methods were used to estimate freedom from late endoleak, early and late
reintervention, and survival.
Results:Analyzed were 49 Ancure, 47 AneuRx, 104 Excluder, and 38 Zenith grafts. Themean follow-upwas 24.7months
(range, 1-87 months). The initial technical success was 99%. The perioperative complication rates for groups L1, L2, and
L3 were 13%, 21%, and 24%, respectively (P  .289). Proximal type I early endoleaks occurred in 12%, 42%, and 53% in
groups L1, L2, and L3, respectively (P < .001). Intraoperative proximal aortic cuffs were needed to seal proximal type I
endoleaks in 10%, 38%, and 47% in L1, L2, and L3 groups, respectively (P < .0001). However, the rate of late
reintervention was comparable in all groups. Postoperatively, the size of the abdominal aortic aneurysm decreased or
remained unchanged in 95%, 94%, and 88% in L1, L2, and L3, respectively (P  .660). Rates of freedom from late type
I endoleak at 1, 2, and 3 years were 84%, 82%, and 80% for L1; 68%, 54%, and 54% for L2; and 71%, 71%, and 53% for
L3 (P  .0263). Rates of freedom from late intervention at 1, 2, and 3 years were 96%, 94%, and 92% for L1; and 94%,
83%, and 83% for L2; and 93%, 93%, and 93% for L3 (P  .5334).
Conclusions: EVAR can be used for patients with a short aortic neck; however, it was associated with a significantly higher
rate of early and late type I endoleaks, resulting in an increased use of proximal aortic cuffs for sealing the endoleaks.
(J Vasc Surg 2009;50:738-48.)The standard of care for the treatment of abdominal
aortic aneurysms (AAA) has been open surgical repair since
it was first described in 1951.1 The treatment of AAA was
revolutionized in the last decade with the advent of endo-
vascular aneurysm repair (EVAR) with stents in 1991.2
The suitability for EVAR, based on the manufacturers
instructions for use (IFU), requires a specific length of
infrarenal aorta free of aneurysm and severe infrarenal aortic
angulation. Initially, the proximal neck criteria for EVAR
included a neck length of 15 mm, a neck diameter be-
tween 17 and 25 mm, an aortic neck angulation of 45°,
and 10% to 20% oversizing.However, with the liberal use of
endovascular stent grafting over the last few years, and the
addition of larger-diameter devices, a neck length of 15
mm, an aortic neck diameter of 25 mm, and an aortic
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738neck angulation of 45° have been used. The recommen-
dations are a minimum of 10 mm of infrarenal aorta free of
aneurysm for the Talent stent graft3 (Medtronic, Inc, Santa
Rosa, Calif) and 15 mm for all other stent grafts.
Strict adherence to the IFU specific for each stent graft
carries a low mortality and morbidity. Conversely, devia-
tion from the specific IFU may lead to negative effects on
late results and outcomes.4 The envelope to treat AAA is
pushed beyond the recommendations and IFU; hence, a
significant number of patients with AAAs in the United
States are presently being treated by EVAR. The propor-
tion of AAA patients found suitable for EVAR has increased
significantly, from a reported 20% in the early stage to 45%
to 80% more recently.5-8
This present study analyzes the correlation of aortic
neck length to early and late clinical outcomes.
METHODS
The study protocol was approved by the Institutional
Review Board of West Virginia University/Charleston
Area Medical Center.
Patients. Between January 2000 and July 30, 2007,
523 patients underwent EVAR at our institution using a
variety of devices approved by the United States Food and
Drug Administration. The grafts were Ancure (Guidant
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Rosa, Calif), Excluder (W. L. Gore & Assoc, Flagstaff,
Ariz), and Zenith (Cook Corp, Indianapolis, Ind). This
study analyzed only 238 patients whose EVAR procedure
was done by two of our full-time academic faculty (A. F. A.
and P. A. S.). Patients treated by nonacademic physicians
were excluded because we had no control over their follow-
up. Also excluded were patients who lacked preoperative
infrarenal aortic neck measurements (primarily due to lack
of good quality computed tomography [CT] scanning),
patients undergoing EVAR for ruptured AAA, and patients
who lacked at least 1 year of follow-up.
Prospectively collected data were supplemented with a
retrospective review of medical records (Vascular Center of
Excellence charts) and radiologic images obtained before
the operation. The preoperative workup of these patients
included CT angiography (CTA), color duplex ultrasound
(DUS) imaging, and arteriography to select patients for
EVAR. Preoperative arteriograms were obtained in all pa-
tients using a marked pigtail catheter. The demographic
and clinical characteristic profiles, aortic neck anatomic
characteristics, operative details, and intraoperative and
30-day perioperative complications or events were re-
corded.
Every effort was made to follow the selection criteria
recommended by the manufacturers of these devices. De-
vice selection was based on physician preference. All proce-
dures were performed in an independent Circulatory Dy-
namic Laboratory with the patient under epidural or
general anesthesia, based on the physician’s choice, using
conventional fluoroscopy (General Electric Medical, Mil-
waukee, Wisc). All devices were inserted, and patients were
followed up, according to the manufacturers’ recommen-
dations. Every effort was made to deploy the endovascular
device flush with the level of the lowest renal artery.
All patients were encouraged to participate in our post-
operative surveillance protocol, which included CTA or
color DUS imaging, or both, and plain abdominal radiog-
raphy at 1, 3, 6, and 12 months, then every 12 months
thereafter. In our early experience, we were strict about
combining CTA and color DUS imaging, which were
repeated at these time intervals. During the last few years,
however, our protocol was modified so that all patients
were followed up using color DUS imaging every 6
months, and CTA was only done if the DUS image showed
a significant change in the size of the residual AAA sac
(0.5 cm).
CT scanning protocol. The standard CT follow-up
protocol, with and without intravenous contrast material,
required a CT section thickness of 3 mm. The proximal
aortic neck diameter was recorded in the minor access from
adventitia to adventitia, just below the lowest renal artery.
Another measurement was made at 15 mm below the
lowest renal artery or at the distal end of the aortic neck in
patients with a short neck (15 mm). The infrarenal aortic
neck was measured on CTA using multiplanar reconstruc-
tion as the distance between the lowest renal artery and the
point of the initial aneurysm dilatation, or where the infra-renal aortic diameter increased to 3 mm of the proximal
neck diameter. The aneurysmal sac size was defined as the
maximum transverse diameter and was also measured from
adventitia to adventitia (the outer diameter). Details of
these measurements, specifically the neck anatomy, were
reviewed separately without the knowledge of the early and
late clinical outcome of these patients.
AAA largest minor access diameter at 12 months
and at the last follow-up. Pretreatment images were used
to measure AAA stability or shrinkage, as recommended by
the Ad Hoc Committee for the Standardized Reporting
Practice in Vascular Surgery.9 Significant AAA diameter
change was defined as 5 mm, and shrinkage was defined
as 5 mm. Endograft migration was determined by mea-
suring the distance from the lowest renal artery and the
most cephalad portion of the stent graft, as seen on CTA
images. Significant migration was defined as displacement
of 10 mm from the predischarge study or any displace-
ment requiring secondary intervention.
For clinical applications and statistical analysis, the aor-
tic neck lengths in our study were classified into 15 mm
(L1), 10 to 15 mm (L2), and 10 mm (L3).
Endoleak was determined using CT, based on extrava-
sation of contrast between the prosthesis and the aneurysm
wall or by color DUS imaging, or both, where the flow and
spectral signals were outside the prosthesis. If the CT and
DUS results differed, contrast arteriography was done to
confirm the endoleak. In general, CT was the gold stan-
dard. Primary or early endoleak was defined as a leak
detected30 days of the procedure, and a secondary or late
endoleak was defined as a leak observed 30 days.
The primary end points for analysis for this study included
early outcome (30 days postoperatively); specifically, the inci-
dence of early proximal aortic endoleak (type I), use of prox-
imal aortic neck extension or cuff, other secondary interven-
tions, technical success, and surgical conversion. A proximal
aortic cuff was used to provide greater radial force and, if
necessary in some patients, to extend the graft closer to the
renal arteries. Secondary early outcome included operative
blood loss, transfusion requirement, volume of contrast used
during implantation, stent graft patency, other endoleaks (dis-
tal type I, type II, III, and IV), and other perioperative
morbidity or mortality.
Technical success was defined from the periprocedural
period through the first 24 hours postoperatively, which
requires successful introduction and deployment of the
stent graft in the absence of surgical conversion, death, or
type I endoleak persisting beyond the initial surgery. Late
clinical outcomes included type I endoleak, other types of
endoleak, stent graft patency, aortic sac expansion, conver-
sion to open repair, stent graft migration, aneurysm rup-
ture, secondary interventions, and aneurysm-related death.
Statistical methods. The data analysis was performed
using SAS 9.1 software (SAS Institute, Cary, NC). Basic
descriptive statistics, such as means and standard deviations
for continuous variables and proportions and frequencies
for categoric variables, were used to analyze the data.
Comparisons between the groups were performed using
(%).
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categoric variables and t tests for continuous variables to
determine statistically significant differences. Logistic re-
gression was used to predict which risk factors were associ-
ated with early/late intervention and early/late endoleak.
Each factor (early endoleak and early intervention) was
looked at separately. The model included age, gender, race,
coronary artery disease, chronic renal disease, type of graft,
neck length, neck angle, and at least one complication. The
Kaplan-Meier method was used to estimate survival distri-
butions (survival, freedom from late endoleak, freedom
from late intervention, and EVAR patency) for the groups.
The test statistic for comparison between these two survival
distributions was based on the log-rank test. An   0.05
was used to determine statistical significance.
RESULTS
EVAR procedures in 238 patients were analyzed, in-
cluding 49 Ancure, 47 AneuRx, 104 Excluder, and 38
Zenith devices. The mean follow-up was 24.7 months
(range, 1-87 months). The overall initial technical success
rate was 99%. All AneuRx, Excluder, and Zenith devices
were successfully deployed. Failures were recorded with
two Ancure devices: One was secondary to failure of intro-
duction for the original model of the Ancure device, which
was converted to AneuRx in the same procedure, and the
other failed due to iliac artery obstruction/rupture and the
patient underwent an open repair.
The demographic and clinical characteristics were compa-
rable for all devices except for the Ancure device, where there
were a statistically significantly higher number of men, pa-
tients with chronic obstructive pulmonary disease, congestive
heart failure, coronary artery disease, and chronic kidney
disease. This was probably a reflection of our early selection
process, wherein we selected patients for the Ancure device
Table I. Abdominal aortic aneurysm characteristics by typ
Characteristica
Excluder Zenith
(n  104) (n  38)
AAA size, cm
Pre-op 6.03 (4.2-9.1) 6.5 (4.6-8.5
Post-op 5.44 (3-9.1) 6.01 (2.8-10
Mean difference –0.57 (–3.7 to 1.9) –0.5 (–1.9 to
Neck size, mm 23.8 (16-28) 25.7 (16-32)
AAA size
Increased 6 (6) 3 (9)
No change 47 (48) 14 (41)
Decreased 45 (46) 17 (50)
Neck length
10 mm 12 (12) 4 (11)
10 to 15 mm 13 (13) 3 (8)
15 mm 77 (75) 31 (82)
Neck angle
45° 57 (56) 22 (58)
45 to 60° 23 (23) 5 (13)
60° 21 (21) 11 (29)
AAA, Abdominal aortic aneurysm; NS, not significant.
aContinuous data are presented as mean (range); categoric data as numberwho were too high-risk for an open procedure.Table I summarizes the device type and AAA charac-
teristics. Patients who underwent a repair with a Zenith
device had a significantly larger AAA size than the other
devices (6.5 cm, P .0223); however, the mean difference
between perioperative and postoperative AAA sizes was not
statistically significant. The size of the AAA sac decreased or
stayed the same in most of these patients. A higher number
of patients with the Excluder devices also had a shorter neck
length (10 mm or 10 to 15 mm, P  .0705).
Ancillary procedures were done more often in patients
with Ancure: 38% vs 9% for AneuRx, 10% for Excluder, and
20% for Zenith (P .001). Most of these procedures were
percutaneous transluminal angioplasty (PTA) and stenting
or common femoral artery endarterectomy with patch an-
gioplasty, or both.
The demographic and clinical characteristics according
to neck length are summarized in Table II. These charac-
teristics were somewhat similar, except for gender and the
incidence of coronary artery disease.
Table III summarizes aortic neck length and aortic
characteristics. There were no statistically significant differ-
ences in these parameters according to neck length. Post-
operatively, the size of the AAA decreased or remained
unchanged in 95%, 94%, and 88% in L1, L2, and L3
patients, respectively (P .660). Similarly, the difference in
aortic neck angle in the three groups was not significant.
Table IV summarizes the correlation of aortic neck
length and intraoperative/hospital variables. The mean
fluoroscopy time, mean amount of contrast, and mean
transfusion were not statistically significant.
The overall perioperative complications were some-
what similar in regards to neck length; however, the peri-
operative mortality rate was statistically higher in patients
with a neck length of10 mm and 10 to15 mm (6% and
8%, P  .0173, Table V). This increase in death may be
device
AneuRx Ancure
P(n  47) (n  49)
5.74 (4.5-7.1) 5.76 (4.2-8.5) .0223
5.22 (3.2-7.5) 4.98 (3.2-8.5) .0524
–0.52 (–2.3 to 2.3) –0.8 (–3.1 to 0.8) .375
24.1 (17-26) 22.9 (18-26) .1316
2 (5) 1 (3) .8627
21 (57) 17 (50)
14 (38) 16 (47)
1 (2) 0 .0705
4 (9) 4 (9)
42 (89) 43 (91)
32 (68) 37 (80) .0482
9 (19) 6 (13)
6 (13) 3 (7)e of
)
.6)
2.3)secondary to the complexity of the procedure. There were
nifican
(%).
) vs 19
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 4 AbuRahma et al 741four perioperative deaths, three secondary to myocardial
infarction, and one secondary to multisystem failure. There
was no renal artery loss; however, a small percentage of
patients sustained acute renal failure in the various groups,
which was not statistically significant.
Table VI summarizes the correlation of neck length and
Table II. Demographics and clinical characteristics by nec
Variablea
L1 (15 mm)
(n  195)
Male 163 (84)
Age, y 74.16 (53-88)
Hypertension 158 (81)
COPD 83 (43)
Current tobacco use 50 (26)
Previous tobacco use 98 (50)
Congestive heart failure 35 (18)
Coronary artery disease 131 (67)
Home oxygen use 17 (9)
Diabetes mellitus 48 (25)
Chronic renal disease 57 (29)
Hyperlipidemia 112 (57)
Follow-up, mon 26.31 (0.1-60.8)
COPD, Chronic obstructive pulmonary disease; L, neck length; NS, not sig
aContinuous data are presented as mean (range); categoric data as number
Table III. Abdominal aortic aneurysm characteristics by n
Variablea
L1 (15 mm) L
(n  195)
AAA size, cm
Pre-op 5.95 (4.2-8.5)
Post-opb 5.36 (2.8-10.6)
Mean difference –0.60 (–3.7 to 2.3) –
Neck size, mm 23.89 (16-32) 2
Post-op AAA size
Increasedb 9 (5)
No change 83 (49)
Decreased 77 (46)
Neck angle
45°c 128 (66)
45 to 60° 35 (18)
60° 31 (16)
AAA, Abdominal aortic aneurysm; L, neck length; NS, not significant.
aContinuous data are presented as mean (range); categoric data as number
bAt end of follow-up.
c21 patients (52.5%) with45° angle had15 mm neck length (L2 and L3
Table IV. Intraoperative and hospital variables by neck le
Variables, mean (range)
L1 (15 mm)
(n  195)
Fluoroscopic time, min 25.5 (8-81)
Estimated blood loss, mL 263.3 (0-2100)
Transfusion amount, U 0.72 (0-11)
Contrast amount, mL 135 (30-317)
Length of stay, d 5.1 (1-43)
L, Neck length; NS, not significant.the incidence of endoleak and intervention. The incidenceof early type I endoleak and all early endoleaks was 53% in
patients with a short neck (10 mm), which was statistically
significantly higher (P  .0001). Similarly, the incidence of
late type I endoleak was higher in patients with a short neck
(12%, P .05). The differences in the outcomes between the
length of the neck and the graft type could not be determined
gth
(10 to 15 mm) L3 (10 mm)
P(n  24) (n  17)
14 (58) 12 (71) .0064
4.79 (48-91) 71.71 (48-91) .4264
23 (96) 15 (88) .1849
7 (29) 6 (35) .4046
4 (17) 2 (12) .3012
13 (54) 11 (65) .5034
3 (13) 0 .1416
11 (46) 7 (41) .0185
1 (4) 0 .4853
6 (25) 2 (12) .4842
5 (21) 3 (18) .4374
14 (58) 7 (41) .4225
7.82 (0.1-61.4) 18.14 (0-86.9) .0826
t.
length
to 15 mm) L3 (10 mm)
Pn  24) (n  17)
(4.5-9.1) 6.22 (4.3-8.1) .2136
(4.2-9.1) 5.64 (3.3-9.8) .3539
(–1.9 to 1.9) –0.53 (–3.1 to 9.8) .952
(18-30) 25.38 (20-32) .0989
(6) 2 (13) .6606
(50) 6 (38)
(44) 8 (50)
(52) 9 (53) .3603
(17) 4 (24)
(30) 4 (24)
patients (47.5%) with45° angle had L2 and L3 neck length (P .1065).
2 (10-15 mm) L3 (10 mm)
P(n  24) (n  17)
27.4 (13-61) 29.5 (16-50) .4667
254 (40-1000) 224 (100-400) .7844
1.25 (0-6) 0.71 (0-6) .3641
117 (45-184) 145 (54-272) .3274
4.6 (1-16) 4.4 (2-10) .7609k len
L2
7
1eck
2 (10
(
6.23
5.74
0.56
3.65
1
9
8
12
4
7
(%).ngth
Lbecause only 17 patients had a short neck (10mm), and the
imary
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used for most short necks). Seven of the 12 with the Excluder
device had type I early endoleaks.
Proximal aortic cuff extensions were used to seal early
type I endoleaks in 47% of patients with a short neck vs 10%
in patients with a 15-mm neck (P  .0001). Overall,
there were more early interventions in patients with a short
neck (P .0001). Proximal cuff extensions were needed in
27% of Excluder grafts and 13% of the AneuRx grafts, in
contrast to 0% for the Zenith graft. However, the Excluder
group had more patients with shorter (P  .07) and angu-
lated (P  .048) necks.
No correlation was found between the mean neck size
and the incidence of type I endoleak. The mean neck size
for patients with no early endoleak was 23.96 mm com-
pared with 23.88 mm for patients with type I early en-
doleaks and 24.2 mm for type II early endoleaks.
Neck length and fate of early endoleak and type of
early intervention. As noted in Table VI, a proximal
Table V. Perioperative complications by neck lengtha
Complication, No. (%)
L1 (15 mm
(n  195)
Myocardial infarction 3 (2)
Iliac rupture 1 (1)
Graft limb thrombosis/acute limb ischemia 9 (5)
Deep vein thrombosis 2 (1)
Systemic embolization 0
Hematoma/bleeding 4 (2)
Wound infection 4 (2)
Sepsis 1 (1)
Colon ischemia 5 (3)
Acute renal failure 3 (2)
Paralysis 0
Perioperative death 1 (1)
All complications 26 (13)
L, Neck length; NS, not significant.
aAt least one complication.
Table VI. Endoleak and intervention by neck length
Endoleak/intervention,
No. (%)
L1 (15 mm)
(n  195)
Early endoleaks
Type I 24 (12)
Type II 19 (10)
Type IV 5 (3)
All early endoleaks 48 (25)
Type I Rx w/aortic cuff 20 (10)
Late endoleaks
Type Ia 11 (6)
Type II 18 (11)
Type III 0
All late endoleaks 29 (17)
Early interventionb 30 (15)
Late intervention 10 (5)
L, Neck length; NS, not significant.
aTwo L1 patients with late type I endoleak were secondary to migration.
bMost of these were done for type I proximal endoleak noted during the praortic cuff extension was inserted in eight of nine patientswith L3 neck anatomy to seal their early type I endoleak,
except three who needed Palmaz stents in addition to aortic
cuff extensions. These early proximal type I endoleaks were
noted during the primary surgery. In the remaining patient,
the type I endoleak (detected postoperatively) decreased,
with no significant change in the aortic sac size at 12
months. The completion angiogram also documented 10
patients with a L2 neck who had type I early endoleak.
Eight of these patients were treated with proximal aortic
cuff extension and sealed immediately, and one was treated
with aortic cuff extensions that decreased the endoleak, and
it sealed 6 months later. Early type I endoleaks occurred in
24 patients with L1 neck anatomy; of these, 20 were treated
with proximal aortic cuff extensions only, and all sealed
immediately. One patient each of the remaining four pa-
tients sealed at 3 months, 6 months, 12 months, and 24
months postoperatively, with no significant change in the
AAA sac size. An early type II endoleak in one patient with
L2 neck anatomy sealed 6 months later. There were 19
L2 (10 to 15 mm) L3 (10 mm)
P(n  24) (n  17)
2 (8) 0 .1238
0 0 1
1 (4) 1 (6) .8337
0 0 1
1 (4) 0 .1737
0 0 1
0 1 (6) .3785
0 0 1
1 (4) 1 (6) .3503
1 (4) 1 (6) .2087
1 (4) 1 (6) .0296
2 (8) 1 (6) .0173
5 (21) 4 (24) .2893
(10 to 15 mm) L3 (10 mm)
P(n  24) (n  17)
10 (42) 9 (53) .0001
1 (4) 0
0 0
11 (46) 9 (53) .0071
9 (38) 8 (47) .0001
3 (15) 2 (12) .044
4 (20) 2 (12)
0 1 (6)
7 (35) 5 (31) .086
9 (38) 8 (47) .0001
2 (8) 2 (12) .321
surgery, which were corrected by proximal aortic cuffs.)L2patients with L1 neck anatomy who had type II endoleak,
ccord
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each sealed at 3 months, 16 months, and 46 months. The
three remaining patients had persistent type II endoleaks,
two at 12months and one at 36months, with no significant
change in the AAA sac size.
Overall, eight L3 patients and nine L2 patients required
early 30-day perioperative intervention with proximal aor-
tic extensions to seal type I proximal endoleaks. Thirty
patients with L1 neck anatomy had early intervention.
These included 20 proximal aortic cuff extensions to seal
proximal type I early endoleaks, 2 groin explorations for
bleeding, 2 lysis/PTA, 4 thrombectomies, and 2 patients
with Ancure devices required stent grafts for treatment of
iliac rupture. Overall, proximal aortic cuff extensions were
used seal to 37 of 43 (86%) of the proximal type I early
endoleaks detected during the primary surgery, with no
significant renal artery loss or noticeable complications.
However, three of these proximal aortic cuffs required an
extra Palmaz stent to aid in sealing proximal endoleaks in
patients with L3 neck anatomy.
Neck length and late endoleak. Rates of freedom
from late endoleak at 1, 2, and 3 years were, respectively,
10.9%10-<15
SE
67.7%100%10-<15
82010-<15
At 
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71.2%100%<10
84.0%100%>15%
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Fig 1. Freedom from late endoleaks a84%, 82%, and 80% for L1 patients; 68%, 54%, and 54% forL2 patients; and 71%, 71%, and 53% for L3 patients (P 
.0263, Fig 1).
Neck length and late reintervention. Rates of free-
dom from late intervention at 1, 2, and 3 years were,
respectively, 96%, 94%, and 92% for L1 patients; 94%, 83%,
and 83% for L2 patients; and 93%, 93%, and 93% for L3
patients (P  .533, Fig 2).
Neck length and fate of late endoleak and type of
late intervention. Five patients with L3 anatomy had late
endoleaks, two of which were type I endoleaks. One was an
early type I endoleak that was present at 12 months, and
one was noted at 6 months; neither was associated with
significant AAA sac size changes. Two patients had late type
II endoleaks, of which one sealed at 6 months postopera-
tively and one sealed at 12 months. The fifth patient had a
type III endoleak, which was noted at 40 months and
treated with an aortic cuff extension.
Seven patients with L2 neck anatomy had late en-
doleak; three were late type I endoleaks, and four were type
II endoleaks. The three late type I endoleaks were early
endoleaks that were treated with proximal aortic cuffs,
reappeared as late endoleaks, but sealed between 3 and 6
15.0%.0%
54.2%.2%
23
53.4%.2%
80.0%.6%
3.6%3%
456
18.0%.3%
25
doleak
p
364
Neck Length
>15mm
>15mm-censored
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<10mm
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3.
6
12
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 U
2
3months later. In the four patients with late type II en-
accor
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9, 18, and 48months. All were associated with a stable AAA
sac size.
Late endoleaks occurred in 29 patients with L1 neck
anatomy; 12 were type I and 17 were type II. Four of the
late type I endoleaks were originally early endoleaks and
sealed as described earlier in 3 to 24 months. Eight others
were new late type I endoleaks. Two were distal iliac
endoleaks at 12 and 18 months and were treated with a
distal iliac extender. One was noted at 12 months later
(graft migration) and was associated with an increasing
AAA sac size, but the patient refused further treatment. The
AAA eventually ruptured, and the patient died. One en-
doleak was noted at 6 months, but the patient died of
gastrointestinal hemorrhage. Three endoleaks were noted
at 6 and 12 months and were treated with proximal aortic
cuff extenders. The remaining endoleak had graft migra-
tion at 30 months and was treated with a proximal aortic
cuff.
Late type II endoleaks occurred in 17 patients with L1
neck anatomy. Six were present as early endoleaks and three
sealed (from 3 to 46 months) with no intervention; the
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Fig 2. Freedom from late interventionother three persisted at 36 months with no significantchange in AAA sac size. The remaining 11 patients had late
type II endoleaks. Six sealed between 9 and 27months with
no intervention, and the endoleaks in the remaining five
patients persisted for 6 to 48 months with no significant
AAA sac size.
Two patients with L3 neck anatomy had late interven-
tion. One patient had a type III endoleak at 36 months,
which was treated successfully with two cuffs, and the other
had an infected endovascular graft that was removed. Two
other patients had L2 neck anatomy. One had late limb
occlusion at 15 months and was treated with a femoro-
femoral bypass graft. A left iliac limb distal type I endoleak
developed in the other and was treated successfully with an
iliac extender.
There were also 10 late interventions in patients with
L1 neck anatomy, including 1 patient with PTA/stent with
lysis for limb ischemia at 3 months, 1 aortic cuff extension
for type I endoleak for graft migration at 30 months, 1 iliac
extension for distal type I endoleak, 1 conversion of patient
with a unibody Cook device with femorofemoral bypass
graft, 1 coil embolization for type II endoleak of the
hypogastric artery at 18 months, 1 distal limb extender for
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1 aortic cuff extension for type I proximal endoleak at 6
months, and 1 graft limb thrombectomy with femorofemo-
ral bypass graft.
Survival rates by neck length. The survival rates at 1,
2, and 3 years were 90%, 82%, and 77% for L1 patients;
76%, 76%, and 76% for L2 patients; and 81%, 72%, and 72%
for L3 patients, respectively (P  .3595, Fig 3).
EVAR patency by neck length. The EVAR patency
rates at 1, 2 and 3 years were, respectively, 95%, 94%, and
93% for L1 patients; 100%, 91%, and 91% for L2 patients;
and and 100%, 89%, and 89% for L3 patients (P  .9534,
Fig 4).
Overall, 13 EVAR procedures failed, eight periopera-
tively and five at a later date. Five were Zenith devices, 4
were Ancure, 3 were Excluder, and 1 was AneuRx. Patients
with perioperative graft thrombosis were successfully treated
with thrombectomy or lysis, or both, and PTA/stenting,
except for three patients who needed femorofemoral bypass
grafting. In the remainingfive grafts, oneAncure graft failed at
1 month and was successfully treated with PTA/stenting and
lysis. Graft infection at 12 months caused one Zenith graft to
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Fig 3. Survival rates accordingfail and it was removed, but the patient died 1 month laterfrom multiple organ system failure. Another Zenith graft
failed 7 months later, and the patient was treated with
a femorofemoral bypass graft. Two other Zenith grafts
failed at 8 and 12 months later, with no further treatment
(patients were asymptomatic).
Multivariate analysis of neck length and adverse
clinical outcomes. Logistic regression analysis showed
that early endoleak was highly associated with a shorter
neck or angulated neck (60°), or both. Early intervention
was also significantly associated with neck length or angu-
lation.
DISCUSSION
The manufacturers of EVAR devices have generally
recommended that an infrarenal neck length of15 mm is
needed to secure proximal graft fixation. However, a
threshold of 10mmhas been proposed recently as sufficient
to produce adequate sealing.10,11 Overall, hostile neck
anatomy is the primary reason that patients with infrarenal
aortic aneurysm must undergo open repair.12 Because of
patients’ preference and referral patterns, a significant por-
tion (53%) of this series of patients treated with EVAR at
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dependent on the radial force of the graft against the
aneurysmal wall and the contact surface between the graft
and the aortic wall. The length of the proximal attachment
in patients with short necks will decrease, leading to a
smaller contact surface and lower friction forces. Therefore,
stent graft migration may occur if displacement forces
exceed the friction forces.13
Device technology, such as suprarenal fixation and
larger diameter grafts, continues to evolve to allow addi-
tional patients to be treated with EVAR who would not
have previously been candidates. However, it is important
to assess outcomes in patients with hostile aneurysm neck
anatomy to weigh the risks and benefits of EVAR and open
repair, especially considering the possibility of the need for
increased late intervention for endoleaks, as well as in-
creased complexity during the procedure that could result
in increased perioperative complications.
Our results showed no significant increase in fluoro-
scopic time, mean amount of contrast used during the
procedure, and mean amount of transfusion required in
patients with a short neck. Fairman et al14 also evaluated if
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Fig 4. Patency of endovascular aneurysm repaircomplicated neck anatomy affected blood loss, transfusionrequirements, and volume of contrast required for EVAR.
There was no significant difference in the procedural vari-
ables of transfusion required or the volume of contrast
used; however, an important difference between the two
studies is that they combined six distinct neck features—
short (15mm), very short (10mm), dilated (28mm),
angulated (45°), calcified, and thrombus-lined—to de-
scribe a complicated neck.
Another important outcome to consider is whether
perioperative complications increase with a short neck anat-
omy. Our study did not demonstrate a significant increase
in the incidence of graft limb thrombosis or acute limb
ischemia and hematoma or bleeding complications with a
short neck. However, perioperative death was significantly
increased with short necks in our study.
One landmark study analyzed the outcomes of EVAR
with neck length from the European Collaborators on Stent-
Graft Techniques for Aortic Aneurysm Repair (EuroSTAR)
registry.8 Leurs et al 8 reported that the 30-day mortality rate
was higher in patients with a neck of15mm compared with
patients with an aortic neck of15mm. This findingwas also
supported by an earlier study by Hovsepian et al15 that
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plications and deaths.15 Other studies have not shown an
increased risk of perioperative mortality with hostile neck
anatomy.12,14 The difference in outcomes could possibly
be secondary to the fact that these studies included other
anatomic criteria for the classification of a hostile neck,
whereas our study only focused on neck length.
The clearest difference with decreasing neck length,
when compared with favorable neck anatomy in our series,
was the incidence of type I early endoleaks. More than
one-half of patients with neck lengths 10 mm had type I
early endoleaks. Most of these required intraoperative
placement of aortic cuffs; however, three patients required
proximal aortic Palmaz stents to seal proximal type I early
endoleaks.
Others have used adjunctive balloon-expandable stents
to treat patients with a hostile neck anatomy.16 Cox
et al16 treated 19 patients with proximal balloon-expandable
stents (17 were Cordis/Palmaz stents) for hostile neck
anatomy, classified as a neck length of 15 mm, neck
diameter of 26 mm, circumferential thrombus at the
proximal neck, angulated neck 60°, and a neck bulge or
reverse tapered neck. From this experience, they concluded
that EVAR may be offered to an expanded patient popula-
tion with hostile neck anatomy with the use of prophylactic
balloon-expandable stents.
Decreased neck length was also associated with signif-
icantly increased rates of late type I endoleaks, although this
did not correlate with a significant increase in late reinter-
vention. Similar results were noted by Leurs et al,8 who
found that short neck lengths predicted early as well as late
type I endoleaks. During a long-term follow-up of 4 years,
the hazard of proximal endoleak was 2 and 2.3 times higher
in patients with a neck of 11 to 15 mm and patients with a
neck of10 mm, respectively, than patients with a neck of
15 mm. Although proximal endoleak was strongly asso-
ciated with rupture of AAA, the incidence of rupture was
too low to reveal any significant association with short neck
or severe aortic neck angulation in the entire study group.17
Fulton et al,18 also using the AneuRx endograft, con-
cluded that patients with unfavorable neck anatomy had sig-
nificantly higher migration, device-related complications, and
secondary intervention rates. However, there was no inci-
dence of open conversion, rupture, or AAA-related deaths.
Their conclusions supported the use of AneuRx devices as a
feasible alternative to open repair, even in patients with a
challenging neck anatomy. Stanley et al,10 using the Zenith
device, also found increasing rates of proximal endoleak.
Other studies that have used multiple anatomic factors
to classify hostile neck anatomy have not found a significant
difference in patients treated with EVAR with hostile neck
anatomy vs “good” neck anatomy in regards to early and
late type I endoleaks.12,19 Again, it is likely that the differ-
ences in these study results, when compared with ours, are
that multiple anatomic factors were included to define a
hostile neck.
Our series found no correlation between EVAR pa-
tency and neck length. Similar results were also noted byFairman et al,14 who concluded that the primary graft limb
patency was 100%, regardless of the neck anatomy.
This study has demonstrated that patients with short
neck anatomy may be treated with EVAR. However, short
necks were clearly associated with an increasing incidence
of type I early endoleak that necessitated early intervention
during the initial procedure to achieve proximal aortic neck
seals. Similar conclusions were also noted by Choke et al.19
Our study was limited by the heterogeneity of devices
used for EVAR. The Ancure device is no longer available on
the market and was not a modular device. We also included
devices with and without suprarenal fixation, which may
affect the outcome with hostile neck anatomy.20 Another
limitation was that device selection for each case was not
randomized, and that there was likely a preference for
certain devices for patients with hostile neck anatomy and
preference for other devices in those with good neck anat-
omy.
Another limitation of our study was that the follow up
for the L2 and L3 groups was much shorter than the L1
group, because in our earlier experience, we were more
strict in the criteria of neck selection, as indicated by the
IFU. During the last few years, however, we became more
liberal in using these devices, specifically for shorter necks,
as seen in the results.
CONCLUSIONS
Although early and late type I endoleaks increased in
patients with short necks, there was not an increased need
for late intervention, only an increased need for early place-
ment of aortic cuffs or early intervention. We did, however,
document an increased rate of perioperative complications
and death in patients with short neck anatomy. This has to
be weighed when making the decision to offer open repair
vs EVAR in these patients.
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